2023
DOI: 10.1002/hsr2.1172
|View full text |Cite
|
Sign up to set email alerts
|

A new set‐up of vanishing antibodies: A biennial follow‐up of five different clients' humoral responses against SARS‐CoV‐2 after systemic vaccination in an oncology hospital in Poland

Abstract: The common severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus has infected approximately 600 million people across 228 countries worldwide, leaving behind natural immunity. 1 Acute COVID-19 infection can cause a cytokine storm that leads to acute respiratory failure (ARDS) and death, 2 while severe inflammatory disease can result in chronic polymyositis syndrome in children (PIMS). 3 Almost half (44.8%) of symptomatic infections in children and adults manifest as varied symptoms related to chro… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 28 publications
0
0
0
Order By: Relevance
“…The results contained in our previous work, which assessed the post-vaccination response to BNT162b2 (Pfizer: Comirnaty) and the reaction after COVID-19, based on a 2-year analysis of 5 cases of differentiated humoral response, showed surprising conclusions [14]. In the summary of the work, administering at least three doses of mRNA vaccine should serve as the basis for immunization, and a three-month interval may be the best alternative to the vaccination schedule for nonimmunocompromised (healthy) people.…”
Section: Discussionmentioning
confidence: 93%
“…The results contained in our previous work, which assessed the post-vaccination response to BNT162b2 (Pfizer: Comirnaty) and the reaction after COVID-19, based on a 2-year analysis of 5 cases of differentiated humoral response, showed surprising conclusions [14]. In the summary of the work, administering at least three doses of mRNA vaccine should serve as the basis for immunization, and a three-month interval may be the best alternative to the vaccination schedule for nonimmunocompromised (healthy) people.…”
Section: Discussionmentioning
confidence: 93%